Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Boehringer Ingelheim GmbH

Boehringer Ingelheim is a research-driven group of companies dedicated to researching, developing, manufacturing and marketing pharmaceuticals that improve health and quality of life.Our business consists of Prescription Medicines, Consumer Health Care and Animal Health. Activities grouped under Industrial Customer include Biopharmaceuticals and Chemicals.
We focus on the production of innovative drugs and treatments that represent major therapeutic advances.


Contact Details:
Binger Str. 173
Ingelheim
55216
Germany
Tel:49/6132/77 0
Fax:49/6132/72 0
Email:info@boehringer-ingelheim.at
WWW:

www.aparatolocomotor.com/




Recent Publications by Boehringer Ingelheim GmbH:

Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis.
BACKGROUND: To assess the responsiveness of the Cough and Sputum...
18th November, 2009
Boehringer Ingelheim GmbH, Binger Strasse 173, D-55216 Ingelheim, Germany. Respir Med. 2009 Nov 14.
DOI Direct Link
Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole.
BACKGROUND: The death of dopaminergic neurons in Parkinson's disease (PD)...
22nd October, 2009
Boehringer Ingelheim GmbH, Ingelheim, Germany. Curr Med Res Opin. 2009 Dec;25(12):2977-87.
DOI Direct Link
Patient-Assessed Versus Physician-Assessed Disease Severity and Outcome in Patients With Nonspecific Pain Associated With Major Depressive Disorder.
OBJECTIVES: This post hoc analysis compared how patients and physicians...
1st April, 2009
University Psychiatric Center, Catholic University of Leuven, Campus Prim Care Companion J Clin Psychiatry. 2009;11(1):8-15.
Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment.
The impact of moderate hepatic impairment on the pharmacokinetics (PK) and...
24th February, 2009
Boehringer Ingelheim GmbH & Co. KG, Birkendorferstr 69, 88397 Biberach an J Clin Pharmacol. 2008 Dec;48(12):1411-9. Epub 2008 Sep 30.
DOI Direct Link
Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder.
The objective of this study was to conduct a meta-analysis of the clinical...
23rd January, 2009
Boehringer Ingelheim GmbH, Ingelheim, Germany. Int Clin Psychopharmacol. 2008 Nov;23(6):317-24.
DOI Direct Link

View more Boehringer Ingelheim GmbH research publications.

Press Releases on Boehringer Ingelheim GmbH:

BioPortfolio Logo
Reportlinker Adds US World Nutraceutical Ingredients Industry 10th November, 2009 Reportlinker
NEW YORK, Nov. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. US World Nutraceutical Ingredients Industry http://www.reportlinker.com
New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Hepatitis C Virus And Therapeutics Market http://www.reportlinker.com/p0119497/World
Drive Alert, Arrive Safe - Better Sleep Could Cut Serious Road Accidents By A Third 17th March, 2009 World Association of Sleep Medicine
Driving hazards caused by sleepiness highlighted on World Sleep Day NEW YORK, March 17 /PRNewswire-USNewswire/ -- Improved diagnosis and treatment of sleep disorders could help to cut fatal or
Dog Owners Unaware That Their Pet May be Suffering From Serious Heart Disease 30th July, 2008
VANCOUVER, Canada, July 30 /PRNewswire/ -- Recently released global research shows that over 50% of dog owners are unaware that their dog may be at risk of heart failure. Heart disease affects one in
Biopharmaceutical Contract Manufacturing: HighTech Business Decisions 1st January, 1970 Hightech Business Decisions
Biopharmaceutical Contract Manufacturing: HighTech Business Decisions Report Indicates New Capacity and Improved Processes Keep the Industry on the Cutting Edge MORAGA, California. March 1,

BioNews Results for Boehringer Ingelheim GmbH:

FoxSexpert: Has 'Female Viagra' Finally Arrived?
FOX WTTG Washington:  Nov 21 2009 4:16AM Matching: boehringer ingelheim gmbh
Global market for anti-depressants on a decline
News-Medical.Net:  Nov 20 2009 11:09AM Matching: boehringer ingelheim gmbh
FoxSexpert: Has 'Female Viagra' Finally
KTTV Fox 11:  Nov 20 2009 11:21AM Matching: boehringer ingelheim gmbh
FoxSexpert: Has 'Female Viagra' Finally Arrived?
MyFox Montgomery:  Nov 20 2009 2:15AM Matching: boehringer ingelheim gmbh
FoxSexpert: Has 'Female Viagra' Finally Arrived?
MyFox New York:  Nov 20 2009 1:51AM Matching: boehringer ingelheim gmbh
Promote your company here: BioNewsCast - Press Release Distribution

View more Boehringer Ingelheim GmbH news.

Boehringer Ingelheim GmbH Patents:

US Patent No.Title
4578264 Retard form of pharmaceuticals with insoluble porous diffusion coatings
5212321 Process for the preparation of trimethylene carbonate
5214159 Meso-lactide
5215744 Methods for the treatment of tumors
5217967 Agent with an antidepressant activity

View more Boehringer Ingelheim GmbH patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 265 times since April 2007, the link to the organisation's website has been followed 48 times

Search for more companies in Ingelheim

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Boehringer Ingelheim GmbH

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.